Abstract: The present invention relates to 9-oxo-9,10-dihydro-6H-pyrano[3,2-b:4,5-b?]dipyridine-8-carboxylic acid derivatives, their manufacture, pharmaceutical compositions containing them and their use as a medicament.
Type:
Grant
Filed:
July 3, 2023
Date of Patent:
April 23, 2024
Assignee:
REJUVERON TELOMERE THERAPEUTICS AG
Inventors:
Patrick Schnider, Fedor Romanov Michailidis, Chien-Chi Hsiao